ANZ Steering Committee Members

 

 

Professor Andrew Spencer - Monash University & The Alfred Hospital, Melbourne
MRDR Coordinating Principal Investigator

Professor Andrew Spencer is Head of Clinical Haematology and Head of Service, Malignant Haematology & Stem Cell Transplantation for Alfred Health. He is Head of the Myeloma Research Group within the Division of Blood Cancers, Australian Centre for Blood Diseases. He has an international reputation as an expert on the development of novel therapeutic approaches principally for multiple myeloma.

Professor John McNeil AM - Monash University, Melbourne

Professor John McNeil is head of the Monash University School of Public Health and Preventive Medicine. His research background is in epidemiology & clinical pharmacology. He has extensive experience in clinical registries and research governance.

Professor P. Joy Ho - Royal Prince Alfred Hospital, Sydney

Professor Joy Ho is Senior Staff Specialist in Haematology, Institute of Haematology, Royal Prince Alfred Hospital and Clinical Professor, Faculty of Medicine, University of Sydney. She is one of the principal investigators of the Myeloma Research Unit at Royal Prince Alfred Hospital.

Associate Professor Erica Wood - Monash University, Melbourne

A/Prof Erica Wood heads the Transfusion Research Unit at Monash University, which operates a number of major clinical registries for important transfusion-related conditions and blood disorders, including the MRDR. She is a consultant haematologist at Monash Health.

Professor Chris Reid - Monash University, Melbourne

Professor Christopher Reid is Associate Director of the Monash Centre of Cardiovascular Research and Education in Therapeutics, and Head of the Clinical Informatics and Data Management Unit at the School of Public Health and Preventive Medicine at Monash University.

Dr Zoe McQuilten - Monash University & St Vincent's Hospital, Melbourne

Dr Zoe McQuilten is a laboratory and clinical haematologist, and has completed a PhD with the Department of Epidemiology and Preventive Medicine at Monash University. Zoe participates in the MRDR and a number of national or bi-national registries relevant to transfusion.

Mr Brian Rosengarten - Myeloma Foundation Australia, Melbourne

Mr Brian Rosengarten is joint founder and current President of the Myeloma Foundation, Australia.

Dr Hang Quach - St Vincent's Hospital, Melbourne

Dr Hang Quach is a consultant haematologist and member of the Australian Medical and Scientific Advisory Group of MFA. Hang has a special interest in biology and immunology of multiple myeloma and novel therapeutics.

 

Dr Peter Mollee - Princess Alexandra Hospital, Brisbane

A/Prof Peter Mollee is Chair, Myeloma Disease Group, Australasian Leukaemia and Lymphoma Group and Director of the Princess Alexandra Hospital Amyloidosis Clinic. Peter is involved in research generated from local, administrative and cancer registry databases.

Associate Professor Hilary Blacklock - Middlemore Hospital, New Zealand

A/Prof Hilary Blacklock is a haematologist at Middlemore Hospital, Auckland, New Zealand; Medical Director of the NZ Bone Marrow Donor Registry, and member of the Board of Trustees of Leukaemia and Blood Cancer NZ.

 

Dr Bradley Augustson - Sir Charles Gairdner Hospital, Perth

Dr Bradley Augustson is a clinical and laboratory haematologist with experience in clinical trials in malignant haematology.

 

Dr Patricia Walker- Frankston Hospital

Dr Patricia Walker is a clinical haematologist at Peninsula Private Hospital and the Alfred Hospital. Her ongoing areas of interest include malignant haematology, stem cell transplantation and survivorship/late effects of treatment. 

Ms Tracy King - Royal Prince Alfred Hospital, Sydney

Ms Tracy King is a clinical research fellow with the Clinical Nursing Research Unit at Sydney University and is an experienced myeloma nurse based at the Royal Prince Alfred Hospital. She established the MFA in NSW, co-founded the HSANZ nurses group and convened the first Nursing Symposium at the International Myeloma Workshop.

 

Dr Noemi Horvath - Royal Adelaide Hospital, Adelaide

Dr Noemi Horvath is a clinical and laboratory haematologist and head of the Myeloma Research Group at Royal Adelaide Hospital.

Dr Krystal Bergin-The Alfred Hospital, Melbourne

Dr Krystal Bergin is a clinical haematologist with Alfred Health  who is currently completing a PhD with the Central Clinical School at Monash University.